Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I/Ib Study Evaluating Single-Agent Inavolisib, Inavolisib Plus Atezolizumab, and Inavolisib Plus Pembrolizumab in PIK3CA-Mutated Cancers

The purpose of the study is to assess the safety and efficacy of inavolisib as a single-agent, in combination with atezolizumab, and in combination with pembro…

PIK3CA-Mutated Cancers

Hoffmann-La RocheNCT06496568